Genomic and Transcriptomic Characterization of Natural Killer T Cell LymphomaJie Xiong, Weili Zhao, Jianda Hu et al.|Cancer Cell|2020Cited by 234
CREBBP/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2/CSF1 axisYao‐Hui Huang, Weili Zhao|Signal Transduction and Targeted Therapy|2021Cited by 230
Advances in targeted therapy for malignant lymphomaLi Wang, Weili Zhao|Signal Transduction and Targeted Therapy|2020Cited by 131
SLC1A1 mediated glutamine addiction and contributed to natural killer T-cell lymphoma progression with immunotherapeutic potentialJie Xiong, Weili Zhao, Nan Wang et al.|EBioMedicine|2021Cited by 51
Cholesterol efflux from C1QB-expressing macrophages is associated with resistance to chimeric antigen receptor T cell therapy in primary refractory diffuse large B cell lymphomaZi‐Xun Yan, Weili Zhao|Nature Communications|2024Cited by 37